JP2018526370A5 - - Google Patents

Download PDF

Info

Publication number
JP2018526370A5
JP2018526370A5 JP2018510510A JP2018510510A JP2018526370A5 JP 2018526370 A5 JP2018526370 A5 JP 2018526370A5 JP 2018510510 A JP2018510510 A JP 2018510510A JP 2018510510 A JP2018510510 A JP 2018510510A JP 2018526370 A5 JP2018526370 A5 JP 2018526370A5
Authority
JP
Japan
Prior art keywords
composition
lmgp
plantarum
use according
lmg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018510510A
Other languages
English (en)
Japanese (ja)
Other versions
JP6957452B2 (ja
JP2018526370A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SE2016/050787 external-priority patent/WO2017034460A1/en
Publication of JP2018526370A publication Critical patent/JP2018526370A/ja
Publication of JP2018526370A5 publication Critical patent/JP2018526370A5/ja
Application granted granted Critical
Publication of JP6957452B2 publication Critical patent/JP6957452B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018510510A 2015-08-25 2016-08-23 腸の感染症及び炎症の治療及び予防のための組成物及び方法 Active JP6957452B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1551099 2015-08-25
SE1551099-3 2015-08-25
PCT/SE2016/050787 WO2017034460A1 (en) 2015-08-25 2016-08-23 Composition and method for treatment and prophylaxis of intestinal infection and inflammation

Publications (3)

Publication Number Publication Date
JP2018526370A JP2018526370A (ja) 2018-09-13
JP2018526370A5 true JP2018526370A5 (enExample) 2019-09-26
JP6957452B2 JP6957452B2 (ja) 2021-11-02

Family

ID=58100550

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018510510A Active JP6957452B2 (ja) 2015-08-25 2016-08-23 腸の感染症及び炎症の治療及び予防のための組成物及び方法

Country Status (16)

Country Link
US (1) US10632159B2 (enExample)
EP (1) EP3341001B1 (enExample)
JP (1) JP6957452B2 (enExample)
KR (1) KR102656709B1 (enExample)
CN (1) CN108135948B (enExample)
AU (2) AU2016312870B2 (enExample)
BR (1) BR112018003123B1 (enExample)
CA (1) CA2995071A1 (enExample)
DK (1) DK3341001T3 (enExample)
ES (1) ES2909430T3 (enExample)
IL (1) IL257568A (enExample)
MX (1) MX395262B (enExample)
PL (1) PL3341001T3 (enExample)
RU (1) RU2738803C2 (enExample)
WO (1) WO2017034460A1 (enExample)
ZA (1) ZA201801266B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7015674B2 (ja) * 2017-10-27 2022-02-15 日清食品ホールディングス株式会社 制御性t細胞の分化誘導剤及び分化誘導方法
JP2019187251A (ja) * 2018-04-19 2019-10-31 国立研究開発法人農業・食品産業技術総合研究機構 発酵物の製造方法及び発酵物
WO2020180037A1 (ko) * 2019-03-04 2020-09-10 경북대학교 산학협력단 인간 장내 미생물 군집 모사 배양용 조성물, 혐기 배양 체계를 이용한 인간 장내 미생물 군집의 모사 배양 방법, 이에 의해 제조된 미생물 제제 및 이의 용도
CN110129221B (zh) * 2019-05-06 2022-05-17 福建晋江国食文化传媒有限公司 乳酸菌hwn19菌株及其应用
CN111358798A (zh) * 2020-03-13 2020-07-03 暨南大学 低聚糖阿魏酸酯的新应用
WO2022039561A1 (ko) * 2020-08-21 2022-02-24 서울대학교산학협력단 클로스트리디움 디피실리 감염의 치료 또는 예방용 조성물
KR102488609B1 (ko) * 2020-09-24 2023-01-12 국립낙동강생물자원관 장내 유해세균 억제 기능을 가진 락토바실러스 파라부크네리 nsmj16 (kacc81129bp) 및 락토바실러스 브레비스 nsmj23(kacc81130bp)
KR102363975B1 (ko) * 2020-12-11 2022-02-17 주식회사 바이오뱅크힐링 락토바실러스 플란타룸 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
CN112625983B (zh) * 2021-03-05 2021-05-28 山东中科嘉亿生物工程有限公司 一种对腹泻有治疗效果的干酪乳杆菌L.Casei21及其应用
US12433922B2 (en) * 2021-09-22 2025-10-07 Asahi Biocycle Co., Ltd. Composition for prophylaxis of enteritis in avian comprising lactobacillus plantarum strain
CN115466699B (zh) * 2022-09-28 2023-03-31 成都大熊猫繁育研究基地 熊猫源唾液乳杆菌及在治疗或预防炎症性肠病中的应用
CN116286476B (zh) * 2023-02-06 2025-09-12 华南理工大学 一株短乳杆菌及其抑菌优化培养方法和应用
CN116875520B (zh) * 2023-07-12 2024-06-14 吉林农业大学 表达核糖体失活蛋白的乳酸菌及其在抗轮状病毒中的应用
KR102628942B1 (ko) * 2023-08-08 2024-01-26 주식회사 바이오뱅크힐링 레비락토바실러스 브레비스 균주, 및 그의 유래의 소포체및 그의 항염증 및 항균 용도
WO2025033636A1 (ko) * 2023-08-08 2025-02-13 주식회사 바이오뱅크힐링 신규 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
CN117467568B (zh) * 2023-09-22 2025-02-14 福建省农业科学院畜牧兽医研究所 一株短乳杆菌zg-7及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1306716B1 (it) * 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
PE20030274A1 (es) * 2001-07-26 2003-05-08 Alimentary Health Ltd Cepas de lactobacillus salivarius
JP5363811B2 (ja) * 2005-09-28 2013-12-11 ノルディスク リバランス アクティーゼルスカブ 治療エフェクターとしてプロバイオティック細菌と発酵穀物を用いるibd及びibsの治療
WO2008064521A1 (en) * 2006-11-30 2008-06-05 Pharmapep Research & Development (Shenzhen) Co., Ltd. Lactobacillus fermentum cms-h002 and use thereof
CN101951922B (zh) * 2007-10-11 2013-03-20 菲尔菲德食品有限公司 治疗小肠感染的包含寡聚糖及不溶性多孔材料的制剂
WO2012142605A1 (en) * 2011-04-15 2012-10-18 Samaritan Health Services Rapid recolonization deployment agent
US9579353B2 (en) * 2011-06-10 2017-02-28 Prothera, Inc. Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes
JP2014166972A (ja) * 2013-02-28 2014-09-11 Kagome Co Ltd 腸炎抑制剤及び飲食品
CN104611275B (zh) * 2015-02-11 2017-10-17 成都与康科技有限公司 植物乳杆菌ucn‑11菌株及其组合物和应用

Similar Documents

Publication Publication Date Title
JP2018526370A5 (enExample)
RU2018105964A (ru) Композиция и способ лечения и профилактики кишечной инфекции и воспаления
JP6444358B2 (ja) ペディオコッカスを含有する医薬組成物および消化器症候群の症状を低減する方法
Patel et al. Clinical application of probiotics in the treatment of Helicobacter pylori infection—a brief review
Caly et al. Alternatives to antibiotics to prevent necrotic enteritis in broiler chickens: a microbiologist's perspective
Marasco et al. Gut microbiota and celiac disease
Jadhav et al. Reviewing the potential of probiotics, prebiotics and synbiotics: advancements in treatment of ulcerative colitis
Elshaghabee et al. Mitigation of antibiotic resistance using probiotics, prebiotics and synbiotics. A review
US20200121740A1 (en) Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes
Chingwaru et al. Potential of Zimbabwean commercial probiotic products and strains of Lactobacillus plantarum as prophylaxis and therapy against diarrhoea caused by Escherichia coli in children
RU2011139211A (ru) Бактериальные штаммы, обладающие высокой противовоспалительной активностью
JP2019508486A5 (enExample)
Sauceda et al. Impact of fruit dietary fibers and polyphenols on modulation of the human gut microbiota
Mahasneh et al. Probiotics and traditional fermented foods: The eternal connection (Mini-Review)
Yang et al. Strategies for applying probiotics in the antibiotic management of Clostridioides difficile infection
Onyenweaku et al. Research Article Health Benefits of Probiotics
Giacchi et al. Multistrain probiotics: the present forward the future
Sharma et al. Pre-and probiotics: Using functional foods in the fight against microbial resistance to antibiotics
Tanriover et al. Use of probiotics in various diseases: Evidence and promises
Anand et al. Expanding avenues for probiotic yeast
de Figueiredo et al. Advances and new perspectives in prebiotic, probiotic and symbiotic products for food nutrition and feed
Lü et al. Research progress on the adhesion mechanism and antagonistic effects against intestinal pathogens of probiotics.
WO2021151956A1 (en) Composition for treating intestinal or pulmonary diseases
Di Cerbo et al. Comparative Use of Bacteriotherapy in Human and Animal Gut Health
Di Cerbo et al. 19 Comparative Use of